Interventional study to improve pertussis and influenza vaccination uptake in pregnant women

被引:0
|
作者
Cremer, Martin [1 ,4 ]
Kaempfen, Siree [2 ]
Lapaire, Olav [3 ]
Hoesli, Irene Mathilde [3 ]
Heininger, Ulrich [1 ]
机构
[1] Basel Univ Basel, Univ Childrens Hosp UKBB, Paediat Infect Dis & Vaccinol Unit, Spitalstr 33, CH-4056 Basel, Switzerland
[2] Univ Basel, Univ Childrens Hosp UKBB, Dept Neonatol, Spitalstr 33, CH-4056 Basel, Switzerland
[3] Univ Womens Hosp Basel, Dept Obstet, Spitalstr 21, CH-4031 Basel, Switzerland
[4] Univ Bern, Ctr Congenital Heart Dis, Dept Cardiol, Pediat Cardiol,Inselspital,Berne Univ Hosp, Freiburgstr 15, CH-3010 Bern, Switzerland
关键词
Pertussis; Influenza; Pregnancy; Immunization; Cocooning; Antibody transfer; ANTIBODIES;
D O I
10.1016/j.ejogrb.2024.02.019
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: Pertussis and influenza are endemic infections and associated with relevant morbidity and mortality in newborns and young infants. The Swiss Federal Office of Public Health has recommended influenza vaccination since 2011 and pertussis vaccination in pregnancy (ViP) since 2013 and expanded to repetition in each pregnancy since 2017. ViP is safe and effective in preventing severe diseases, but implementation is a challenge. We hypothesized that the proportion of women receiving ViP is persistently low despite existing national recommendations. Our primary objective was to compare the proportion of pertussis and influenza vaccine recommendations for and its acceptance by pregnant women before and after an information campaign tailored to obstetricians. Secondly, we aimed to identify reasons for missing or declining ViP. Study design: We conducted a prospective, single-center, single-arm implementation study in the maternity ward at the University Women's Hospital Basel. We performed standardized interviews with women hospitalized for postpartum care before (October to December 2019, Phase 1, n = 262) and after an information campaign (October to December 2020, Phase 2, n = 233) and compared categorical variables using chi-squared or Fisher's exact test and continuous variables using Whitney Mann U test. Results: We found no significant differences in the proportion of recommendation for pertussis ViP (80 % vs. 84 %, p = 0.25) and implementation (76 % vs. 78 %, p = 0.63) between Phase 1 and 2. Main reasons for missing or declining vaccinations were lack of recommendation (62.8 %) and safety concerns regarding the unborn child (17.7 %). In contrast, the proportion of recommendation for influenza ViP (45 % vs. 63 %, p < 0.001) and implementation (29 % vs. 43 %, p < 0.001) increased significantly. Conclusion: Proactive recommendations by obstetricians play a key role in the implementation of ViP but is still insufficient in our setting. We believe that future efforts should aim to explore possible hurdles that impede recommendations by obstetricians for ViP. The focus should be on the needs and experiences of obstetricians in private practice, but also other health care professionals involved in care of pregnant women. Local campaigns do not seem effective enough, therefore national campaigns with new strategies are desirable.
引用
收藏
页码:201 / 209
页数:9
相关论文
共 50 条
  • [41] Benefits of influenza vaccination during pregnancy for pregnant women
    Jamieson, Denise J.
    Kissin, Dmitry M.
    Bridges, Carolyn B.
    Rasmussen, Sonja A.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 207 (03) : S17 - S20
  • [42] Influenza vaccination coverage among Polish pregnant women
    Lukowska, P.
    Biesiada, D.
    Molas-Biesiada, A.
    Dubiel, P.
    Leonczuk, D.
    Ganczak, M.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2020, 30 : V1074 - V1074
  • [43] Influenza Vaccination of Pregnant Women and Protection of Their Infants REPLY
    Madhi, Shabir A.
    Nunes, Marta C.
    Cutland, Clare L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (24): : 2340 - 2340
  • [44] Vaccination against influenza in pregnant women - safety and effectiveness
    Nitsch-Osuch, Aneta
    Wozniak, Kosek Agnieszka
    Brydak, Lidia Bernadeta
    [J]. GINEKOLOGIA POLSKA, 2013, 84 (01) : 56 - 61
  • [45] New recommendations for influenza vaccination for children and pregnant women
    Baltimore, RS
    Jenson, HB
    [J]. CURRENT OPINION IN PEDIATRICS, 2003, 15 (01) : 74 - 76
  • [46] Factors Associated with Seasonal Influenza Vaccination in Pregnant Women
    Henninger, Michelle L.
    Irving, Stephanie A.
    Thompson, Mark
    Avalos, Lyndsay Ammon
    Ball, Sarah W.
    Shifflett, Pat
    Naleway, Allison L.
    [J]. JOURNAL OF WOMENS HEALTH, 2015, 24 (05) : 394 - 402
  • [47] LIFETIME UNFAIR TREATMENT AND ANTIBODY RESPONSE TO PERTUSSIS VACCINATION IN PREGNANT WOMEN
    Celia-Sanchez, Manuela L.
    Cha, Leah
    Miller, Gregory E.
    Ehrlich, Katherine B.
    [J]. PSYCHOSOMATIC MEDICINE, 2022, 84 (05) : A90 - A91
  • [48] Predictors of maternal pertussis vaccination acceptance among pregnant women in Norway
    Hansen, Bo T.
    Winje, Brita A.
    Stalcrantz, Jeanette
    Greve-Isdahl, Margrethe
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [49] Strategy for the Active Surveillance of the Safety of the Pertussis Vaccination in Pregnant Women in the UK
    Donegan, K.
    King, B.
    Bryan, P.
    [J]. DRUG SAFETY, 2013, 36 (09) : 898 - 898
  • [50] Differences between influenza and pertussis vaccination uptake in pregnancy: a multi-center survey study in Italy
    Vilca, Luz Maria
    Sarno, Laura
    Cesari, Elena
    Vidiri, Annalisa
    Antonazzo, Patrizio
    Ravennati, Francesca
    Cavaliere, Anna Franca
    Guida, Maurizio
    Cetin, Irene
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31 (06): : 1150 - 1157